# FDA Inspection 1167810 - University of Texas MD Anderson Cancer Center - March 24, 2022

Source: https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/7c9a0499-792b-43f9-90ba-54d48245f465
Source feed: FDA_Inspections

> FDA Inspection 1167810 for University of Texas MD Anderson Cancer Center on March 24, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167810
- Company Name: University of Texas MD Anderson Cancer Center
- Inspection Date: 2022-03-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1167810 - 2022-03-24](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/44ab8467-c3ed-4d65-a079-9fc2ec351ae0)
- [FDA Inspection 1030030 - 2017-10-26](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/d787b14f-8a35-4532-833e-d9891b6fabcf)
- [FDA Inspection 1030030 - 2017-10-26](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/281bf8f6-83d3-4fbe-a738-bfcfef4fc8e6)

Company: https://www.keypedia.com/companies/university-of-texas-md-anderson-cancer-center/3dbc2488-0079-4d5c-a6e5-0cc8ada2709c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d